Hellman Jordan Management CO Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Hellman Jordan Management CO Inc

  • $58.9 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 27, 2022
SELL
$27.79 - $50.61 $131,724 - $239,891
-4,740 Closed
0 $0
Q4 2021

Jan 26, 2022
BUY
$58.09 - $82.51 $275,346 - $391,097
4,740 New
4,740 $314,000
Q4 2020

Jan 29, 2021
SELL
$43.82 - $85.37 $2.19 Million - $4.27 Million
-50,000 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$33.21 - $51.27 $1.66 Million - $2.56 Million
50,000 New
50,000 $2.15 Million

Others Institutions Holding ARWR

# of Institutions
291
Shares Held
91.6M
Call Options Held
1.33M
Put Options Held
549K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.12B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Hellman Jordan Management CO Inc Portfolio

Follow Hellman Jordan Management CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hellman Jordan Management CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Hellman Jordan Management CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email